Cargando…

4th Immunotherapy of Cancer Conference (ITOC4), March 20–22, 2017, Prague, Czech Republic

Detalles Bibliográficos
Autor principal: Le, Duc H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405185/
https://www.ncbi.nlm.nih.gov/pubmed/28396266
http://dx.doi.org/10.1016/j.ebiom.2017.04.001
_version_ 1783231723886084096
author Le, Duc H.
author_facet Le, Duc H.
author_sort Le, Duc H.
collection PubMed
description
format Online
Article
Text
id pubmed-5405185
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-54051852017-05-05 4th Immunotherapy of Cancer Conference (ITOC4), March 20–22, 2017, Prague, Czech Republic Le, Duc H. EBioMedicine In Focus Elsevier 2017-04-04 /pmc/articles/PMC5405185/ /pubmed/28396266 http://dx.doi.org/10.1016/j.ebiom.2017.04.001 Text en © 2017 The Author http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle In Focus
Le, Duc H.
4th Immunotherapy of Cancer Conference (ITOC4), March 20–22, 2017, Prague, Czech Republic
title 4th Immunotherapy of Cancer Conference (ITOC4), March 20–22, 2017, Prague, Czech Republic
title_full 4th Immunotherapy of Cancer Conference (ITOC4), March 20–22, 2017, Prague, Czech Republic
title_fullStr 4th Immunotherapy of Cancer Conference (ITOC4), March 20–22, 2017, Prague, Czech Republic
title_full_unstemmed 4th Immunotherapy of Cancer Conference (ITOC4), March 20–22, 2017, Prague, Czech Republic
title_short 4th Immunotherapy of Cancer Conference (ITOC4), March 20–22, 2017, Prague, Czech Republic
title_sort 4th immunotherapy of cancer conference (itoc4), march 20–22, 2017, prague, czech republic
topic In Focus
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405185/
https://www.ncbi.nlm.nih.gov/pubmed/28396266
http://dx.doi.org/10.1016/j.ebiom.2017.04.001
work_keys_str_mv AT leduch 4thimmunotherapyofcancerconferenceitoc4march20222017pragueczechrepublic